NewsSource: EClinCloud

Livestream Preview | How AI Helps Improve Data Quality in Clinical Research

2 min readEClinCloud Editorial Team
Article illustration

Source: EClinCloud. Author: EClinCloud.

Article illustration

Live trailer

Livestream Preview


How AI Helps Improve Data Quality in Clinical Research

Livestream time: June 18, 19:00–20:00

Livestream poster.jpg


Click the reserve button above to register now 👆

Image


As the wave of AI accelerates, clinical research is undergoing a profound transformation. From data capture to quality control, and from process automation to intelligent decision-making, AI is gradually permeating every stage of clinical trials and becoming a key driver for improving efficiency and safeguarding quality.


This livestream will take the form of a dialogue, exploring the current state of AI applications in clinical data management, implementation bottlenecks, and practical solutions. Join the livestream to hear in-depth insights from frontline experts, participate in a live Q&A, and gain practical new ideas.














Speaker Introductions




Image 1.png

Qin Long, PhD

Founder and CEO, EClinCloud

Bringing over 18 years of experience in technology applications for the clinical research industry, Dr. Qin is a pioneer in promoting and implementing technical solutions such as eCOA, EDC, and CTMS in clinical trial research in China, and has long focused on the practical application of AI in clinical trial data management and intelligent decision support to advance a new AI-driven paradigm for clinical research.


Article illustration

Wang Xiao

General Manager, ClinChoice–Meida Data

Wang Xiao has 15 years of experience in clinical trial data analysis and a deep understanding of all aspects of the field, having worked in Australia and Japan and participated in hundreds of clinical projects, including dozens of international multicenter studies. With extensive experience in biostatistics, statistical programming, database programming, and clinical data management, Wang possesses a thorough understanding of both Chinese and international systems as well as substantial hands-on experience conducting domestic and global clinical trials.


Article illustration

Huang Jie

Chief Database Specialist, ClinChoice–Meida Data

Huang Jie has over 15 years of IT development experience and is proficient in various domestic and international EDC systems and database build workflows. With nearly 10 years of deep experience in clinical trial data analysis, Huang has focused in recent years on exploring and applying automation technologies and AI in clinical trial data management.


Click the reserve button above to register now 👆






About EClinCloud


EClinCloud is a leading AI company in the clinical research industry. Driven by AI, it has built an integrated intelligent clinical cloud platform and endpoint assessment technologies, providing global pharmaceutical companies and research institutions with technical products including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, as well as scale management, linguistic validation, rater training, and data quality analysis services to build efficient and accurate digital solutions. Relying on AI prediction models and an intelligent data platform, it dynamically evaluates and helps improve the success rate of drug clinical trials, helping shorten drug and medical device R&D cycles to benefit patients.







Article illustration


Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.